These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6393142)

  • 1. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
    Bergamaschi M; Pierucci L; Ferti C; Corsi G; Branzoli U; Mandelli V
    Prostaglandins Leukot Med; 1984 Oct; 16(1):19-27. PubMed ID: 6393142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo.
    Morley J; Page CP; Paul W; Mongelli N; Ceserani R; Gandolfi C
    Prostaglandins Leukot Med; 1983 Aug; 11(4):391-9. PubMed ID: 6353424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and excitation induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation.
    Caparrotta L; Ceserani R; Mongelli N; Santi-Soncin E; Ragazzi E; Fassina G
    Prostaglandins; 1987 Mar; 33(3):351-62. PubMed ID: 3033748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H; Kutti J
    Acta Haematol; 1985; 73(4):224-7. PubMed ID: 2414956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study.
    de la Cruz JP; Bellido I; Camara S; Martos F; Sanchez de la Cuesta F
    Scand J Haematol; 1986 Apr; 36(4):394-7. PubMed ID: 3086967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of PGI2 production by isolated perfused rat lungs with platelet aggregation test.
    Hartiala J; Toivonen H; Uotila P
    Prostaglandins; 1980 Jul; 20(1):127-34. PubMed ID: 6996035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG; Karim SM; Lau LC
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.